Hepatitis C Virus (HCV) testing Market By Test Kits (Hepatitis C Antibody Test, Hepatitis C RNA Quantitative Test, Hepatitis C RNA Qualitative Test, Hepatitis C RIBA, Hepatitis C Genotype, Viral Load); By End-User (Diagnostic Centers, Hospitals, Blood donation centers) - Global Demand Analysis & Opportunity Outlook 2027

Global Hepatitis C Virus (HCV) testing Market Overview

Hepatitis C is a liver disease which is transmitted from the blood of an infected person by direct contact. Hepatitis C shows significant genetic variation due to high rate of viral RNA mutations in worldwide population. HCV vary in the rate of prevalence around the globe due to six variants (HCV genotypes 1, 2, 3, 4, 5, and 6), and 15 recorded subtypes. Different types of devices are used for the diagnosis of hepatitis C, including HCV antibody test, HCV viral load test, HCV genotype test and liver biopsy. Inexpensive, robust, rapid, and sensitive analytical devices are vital for accurate, effective diagnosis and monitoring of disease treatment.A main concern across the globe and especially in the developing countries is increasing burden of infectious diseases on healthcare system. Burden of hepatitis C virus infection is growing over the years. Approximately 3% of global population is infected with hepatitis C virus infection, according to Institute of Liver and Biliary Sciences, India. HCV leads to chronic infection in 80% of infected patients. Initial testing for hepatitis C virus uses serological assays to detect antibodies against HCV in blood samples.

Market Size & Forecast

Hepatitis C Virus (HCV) testing Market is anticipated to record a significant CAGR over the forecast period. Increase in hepatitis C virus testing market is majorly credited to high incidence of chronic infection with hepatitis C virus. Furthermore, the considerable cause of spread of hepatitis C virus is unhygienic blood donation practices.Among all types of tests, HCV antibody testing is expected to occupy more shares because antibody testing is the primarily used test for HCV testing. Long term use of non-sterile needles for tattooing and body piercing, use of injection drugs and various other practices are common causes for spread of hepatitis C virus infection which are anticipated to propel the market globally.On the basis of regional platform, global hepatitis C Virus (HCV) testing market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region.

Europe is expected to dominate the hepatitis C virus testing market significantly due to increasing prevalence of hepatitis C virus diseases. According to WHO, Europe has 1.5% prevalence of HCV diseases due to high rates of mutation of viral RNA that shows significant variations in genes in population globally. The North-American region is expected to follow in the footsteps of Europe.Asia Pacific is expected to be having lucrative market growth over the forecast period owing to disease prevalence rates in the developing and underdeveloped countries. While Middle East and Africa has a hepatitis C disease prevalence rate of 4.6% and 5.3% respectively, these regions due to lack of proper healthcare infrastructure are not able to access the diagnostic and treatment shares.CLICK TO DOWNLOAD FREE SAMPLE

Market Segmentation

Our-in depth analysis of the global hepatitis C Virus (HCV) testing market includes the following segments:

By Test Kits

• Hepatitis C Antibody Test
• Hepatitis C RNA Quantitative Test
• Hepatitis C RNA Qualitative Test
• Hepatitis C RIBA
• Hepatitis C Genotype
• Viral Load

By End-User

• Diagnostic Centers
• Hospitals
• Blood donation centers

By Region

Global Hepatitis C Virus (HCV) testing Market is further classified on the basis of region as follows:

• North America (United States, Canada), Market size, Y-O-Y growth Market size, Y-O-Y growth & Opportunity Analysis, Future forecast & Opportunity Analysis
• Latin America (Brazil, Mexico, Argentina, Rest of LATAM), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis
• Europe (U.K., Germany, France, Italy, Spain, Hungary, BENELUX (Belgium, Netherlands, Luxembourg), NORDIC (Norway, Denmark, Sweden, Finland), Poland, Russia, Rest of Europe), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis
• Asia-Pacific (China, India, Japan, South Korea, Malaysia, Indonesia, Taiwan, Hong Kong, Australia, New Zealand, Rest of Asia-Pacific), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis
• Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis

Growth Drivers & Challenges

Increase in organ donation globally is expected to boost the hepatitis C testing market as Hepatitis C screening test is compulsory before organ donation. Ascent in changing lifestyle, increased healthcare expenditure and upsurge in government initiatives are some of the key aspects driving the market of hepatitis C virus antiviral testing globally. In addition, growing healthcare awareness in the population about the hepatitis C virus is also fueling the growth of global hepatitis C virus testing market. High incidence of chronic infection with hepatitis C virus has additionally attributed to the testing market. Moreover, unhygienic blood donation practices are significant cause of spread of hepatitis C virus which is expected to push the market further. The surfacing of DAAs (Direct Acting Antivirals) has aroused renewed interest in the establishment and expansion of testing services for HCV after a long period of stagnation which will propel the market more speedily over the forecast period.However, stringent regulation for approval of hepatitis C testing, inadequate insurance coverage and limited access to regular health care is the major factor expected to hamper the hepatitis C virus testing market.

Key Players

• Roche Diagnostics
  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis
• Abbott
• Siemens Healthcare GmbH
• Abbott Laboratories Inc.
• BioGenex
• Bio-Rad Laboratories
• Meridian Bioscience
• Standard Diagnostics, Inc.
• Bayer AG
• Thermo Fisher Scientific Inc.

Scope & Context

Overview of the Parent Market

Analyst View

Segmentation

The Global Hepatitis C Virus (HCV) testing Market is segmented as follows:

• By Test Kits Market Size & Y-O-Y Growth Analysis

• By End-User Market Size & Y-O-Y Growth Analysis
• By Region Market Size & Y-O-Y Growth Analysis

Market Dynamics

Supply & Demand Risk

Competitive Landscape

Porter’s Five Force Model

Geographical Economic Activity

Key Players (respective SWOT Analysis) and their Strategies and Product Portfolio

Recent Trends and Developments

Industry Growth Drivers and Challenges

Key Information for Players to establish themselves in current dynamic environment